Name | tpi287 |
---|---|
Synonyms |
Hexanoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-5-methyl-, (1S,2S,4S,7S,7aR,10aS,11aR,13aS,13bR,13cS)-7,13a-bis(acetyloxy)-1-(benzoyloxy)-9-ethenyl-1,3,4,7,7a,10a,11,11a,13,13a,13b,13c-dodecahydro-2-hydroxy-5,13c,14,14-tetramethyl-2,6-methano-2H-cyclodec[de]oxeto[3,2-g][1,3]benzodioxin-4-yl ester, (2R,3S)-
TPI-287 (1R,2S,5R,7S,11R,12S,15S,17S,18S,19S)-2,12-Diacetoxy-17-hydroxy-15-{[(2R,3S)-2-hydroxy-5-methyl-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)hexanoyl]oxy}-14,19,20,20-tetramethyl-9-vinyl-4,8,10-trioxa ;pentacyclo[9.7.1.1.0.0]icos-13-en-18-yl benzoate |
Description | TPI-287, a blood-brain barrier-permeable microtubule stabilizer, can significantly reduce metastatic colonization of breast cancer in the brain[1]. |
---|---|
Related Catalog | |
In Vivo | TPI-287 (i.v., 18 mg/kg, every 4 days, 41 days) 在接种了 231-BR 乳腺癌细胞的小鼠肿瘤模型中,可以有效减小肿瘤体积,抑制肿瘤的生长[1]。 |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 857.4±65.0 °C at 760 mmHg |
Molecular Formula | C46H63NO15 |
Molecular Weight | 869.990 |
Flash Point | 472.3±34.3 °C |
Exact Mass | 869.419800 |
PSA | 211.68000 |
LogP | 7.97 |
Vapour Pressure | 0.0±0.3 mmHg at 25°C |
Index of Refraction | 1.573 |